LO-3-63 is a Ribociclib analogue featuring a truncated fumaramide group and acts as a CDK4/6 degrader with PROTAC properties. It degrades CDK4/6 in cells via a CUL4DCAF16-dependent pathway.
Target:
PROTACs|||E1/E2/E3 Enzyme|||CDK
* VAT and and shipping costs not included. Errors and price changes excepted
